Politiparty
Politiparty

118th Congress Health

S. 2329: Emerging Pathogen Preparedness Program Authorization Act

Introduced

  1. Introduced (completed)Jul 13, 2023
  2. Passed Senate (not reached)
  3. Passed House (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in Senate, Jul 13, 2023

This bill establishes a program in the Food and Drug Administration's Center for Biologics Evaluation and Research to support the development and approval of biological countermeasures. Authorized activities include the development of quality measures for countermeasures, surveillance programs to monitor countermeasures, and research and development of platform vaccine technology to support emergency use authorization requests.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

1

Bipartisan support.

Who scored on this bill

6 points earned
  1. 1John Hickenlooper D-CO SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by John Hickenlooper

History

  1. Jul 13, 2023Introduced in the Senate by John Hickenlooper.
Show the full action history (2 actions)
  1. Jul 13, 2023Introduced in Senate
  2. Jul 13, 2023Read twice and referred to the Committee on Health, Education, Labor, and Pensions.